Thursday – Clinical Track 5A

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2026.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Management of refractory OAB
Dudley Robinson, MBBS, MD, FRCOG (UK)
Use of botulinum toxin in the neurogenic population
Francisco Cruz, PhD (Portugal)
Botox beyond the bladder: Other uses of botulinum toxin in the pelvis
Philip Toozs-Hobson, MD (UK)
Emerging roles for botulinum toxin in urology and urogynecology
Christopher Chermansky, MD (USA)
Panel Discussion (Q&A)
YesNo
Management of refractory OAB
Dudley Robinson, MBBS, MD, FRCOG (UK)
Use of botulinum toxin in the neurogenic population
Francisco Cruz, PhD (Portugal)
Botox beyond the bladder: Other uses of botulinum toxin in the pelvis
Philip Toozs-Hobson, MD (UK)
Emerging roles for botulinum toxin in urology and urogynecology
Christopher Chermansky, MD (USA)
Panel Discussion (Q&A)
YesNo
Management of refractory OAB
Dudley Robinson, MBBS, MD, FRCOG (UK)
Use of botulinum toxin in the neurogenic population
Francisco Cruz, PhD (Portugal)
Botox beyond the bladder: Other uses of botulinum toxin in the pelvis
Philip Toozs-Hobson, MD (UK)
Emerging roles for botulinum toxin in urology and urogynecology
Christopher Chermansky, MD (USA)
Panel Discussion (Q&A)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Scam Warning

Due to scam emails being sent, please note that INA will NOT email you to wire money to anyone on the Board of Directors or anyone else from the INA.

Join Our Mailing List

Click here to sign up, and then manage your subscription.